In the current study, we found that TFAP2C was remarkably elevated in CRC tissues and high expression of TFAP2C correlated with advanced clinicopathological features, poor prognosis and disease progression in CRC patients. This evidence concerns the gene TFAP2C and colorectal carcinoma.